Chronic Leukemia
Showing 1 - 25 of >10,000
Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Loncastuximab Tesirine
- (no location specified)
Jul 24, 2023
Chronic Lymphocytic Leukemia Patients
Not yet recruiting
- Chronic Lymphocytic Leukemia
-
San Francisco, CaliforniaPower Life Sciences
Jun 2, 2023
Asciminib RMP Study
Not yet recruiting
- Chronic Myeloid Leukemia
- Asciminib
- (no location specified)
Jul 5, 2023
Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life
Not yet recruiting
- Chronic Myelogenous Leukemia - Chronic Phase
- APN and medical management
- +3 more
-
Avignon, Provence-Alpes-Côte d'Azur, FranceCentre Hospitalier d'Avignon, Hôpital Henri Duffaut
Oct 13, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Nemtabrutinib
- +2 more
- (no location specified)
Nov 22, 2023
Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- (no location specified)
Jul 10, 2023
Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)
Not yet recruiting
- Chronic Myelogenous Leukemia
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Oct 12, 2023
Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer
Completed
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Myeloma Coach or CLL Coach Mobile App
- Springboard Beyond Cancer informational website
-
Durham, North CarolinaDuke University
Jun 23, 2023
Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in
Completed
- Chronic Myeloid Leukemia
-
East Hanover, New JerseyNovartis
Nov 20, 2023
Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)
Not yet recruiting
- Relapsed/Refractory Chronic Lymphocytic Leukemia
-
Tianjin, Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Jul 13, 2023
Ponatinib in CML Patients in Chronic Phase
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Therapeutic drug monitoring
- Molecular Response
-
Cagliari, Italy
- +4 more
Nov 3, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Small Lymphocytic Lymphoma
- (no location specified)
Jul 19, 2023
Chronic Leukemia Trial in France (Additional biological samples)
Active, not recruiting
- Chronic Leukemia
- Additional biological samples
-
Besançon, France
- +3 more
May 31, 2022
Chronic Myelomonocytic Leukemia Trial in Indianapolis (CD4CAR)
Not yet recruiting
- Chronic Myelomonocytic Leukemia
- CD4CAR
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 2, 2023
Biomarker for Infection Risk in CLL and MM
Not yet recruiting
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Screening
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
May 3, 2023
MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral
Not yet recruiting
- Myelodysplastic Syndromes
- +3 more
- Subcutaneous azacitidine
- Oral decitabine/cedazuridine
-
Newcastle, New South Wales, AustraliaCalvary Mater Newcastle
May 29, 2023
Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,
Not yet recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- +5 more
- Nemtabrutinib
- +2 more
- (no location specified)
Jul 21, 2023
MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)
Recruiting
- Myelodysplastic Syndromes
- Chronic Myelomonocytic Leukemia
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Jul 30, 2023
Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)
Not yet recruiting
- Chronic Myelomonocytic Leukemia
- Azacitidine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2023
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Recruiting
- Cancer
- +9 more
-
Edmonton, Alberta, CanadaEdith Pituskin
Nov 30, 2022
Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)
Recruiting
- Chronic Lymphocytic Leukemia
- Questionnaires
- Fit Bit
-
Houston, TexasM D Anderson Cancer Center
May 18, 2023
Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any
Active, not recruiting
- Chronic Myeloid Leukemia, Chronic Phase
-
Jena, GermanyUniversity Hospital Jena
Jan 17, 2023
Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -
Recruiting
- Chronic Myeloid Leukemia in Myeloid Blast Crisis
- +3 more
- based decitabine and olverembatinib（HQP1351)chemotherapy
-
Guanzhou, ChinaDepartment of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022
